27 octobre 2015

Atelier sur les critères de brevetabilité

Le 27 octobre 2015, l'Organisation mondiale de la santé, l'Organisation mondiale de la propriété intellectuelle et l'OMC ont organisé conjointement un atelier technique sur les critères de brevetabilité. Cet atelier a donné aux participants un aperçu concret de la manière dont les principaux critères techniques de brevetabilité sont appliqués dans la pratique au niveau des pays et de l'incidence que les différences de définition et d'interprétation peuvent avoir sur la santé publique.

English only

Voir aussi:


The aim was to support participants to engage in a policy debate that is characterized by its highly technical nature and assist them to appropriately frame and assess national patent systems and practices. To do so, the three collaborating agencies provided a brief overview of the legal framework at multilateral, regional and national level. This was followed by an interactive session led by a practitioner who presented and discussed a number of practical cases. The final discussion provided an opportunity to look at matters of public interest and concerns with respect to the design and application of patentability criteria at country level and potential repercussions on public health.

The Workshop took place back to back with the WHO-WIPO-WTO Symposium on “Public Health, Intellectual Property, and TRIPS at 20: Innovation and Access to Medicines; Learning from the Past, Illuminating the Future” that was held at the WTO on 28 October 2015.


14h00 — 14h10

Welcome and introduction

14h10 — 15h15

Patentability criteria and public health

    Patentability criteria pursuant to the TRIPS Agreement
    Roger Kampf, Counsellor, Intellectual Property Division, WTO

    Patentability criteria and patent grant procedures at country level
    Tomoko Miyamoto, Head, Patent Law Section, WIPO

    Impact of patentability criteria on public health
    Peter Beyer, Senior Advisor, Department of Essential Medicines & Health Products, WHO       



15h15 — 17h00

Application of patentability criteria to concrete pharmaceutical patent cases

    Markus Engelhard, Boehmert & Boehmert, Munich/Germany


17h00 — 18h00

Open discussion on patentability criteria and domestic needs

    Moderator: Antony Taubman, Director, Intellectual Property Division, WTO